Categories AlphaGraphs, Earnings, Health Care
JNJ Earnings: All you need to know about Johnson & Johnson’s Q4 2024 earnings results
Johnson & Johnson (NYSE: JNJ) reported its fourth quarter 2024 earnings results today.
Reported sales increased 5.3% year-over-year to $22.5 billion. Operational sales growth was 6.7%.
Net earnings decreased 17% to $3.4 billion, or $1.41 per share, compared to last year. Adjusted EPS decreased 10.9% to $2.04.
Revenue surpassed projections while earnings came in line with estimates.
For full-year 2025, the company expects reported sales of $89.2-90.0 billion and adjusted EPS of $10.50-10.70.
The stock stayed red in premarket hours on Wednesday.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Docusign (DOCU) Earnings: 3Q26 Key Numbers
Docusign, Inc. (NASDAQ: DOCU) reported its earnings results for the third quarter of 2026. Revenue increased 8% year-over-year to $818.4 million. GAAP net income was $83.7 million, or $0.40
Infographic: How Ulta Beauty (ULTA) performed in Q3 2025
Ulta Beauty, Inc. (NASDAQ: ULTA) reported its earnings results for the third quarter of 2025. Net sales increased 12.9% year-over-year to $2.9 billion, driven by comparable sales growth, the Space
Hewlett Packard Enterprise (HPE) Earnings: 4Q25 Key Numbers
Hewlett Packard Enterprise (NYSE: HPE) reported revenue of $9.7 billion for the fourth quarter of 2025, up 14% from the prior-year period in actual dollars and in constant currency. Net
